WallStreetZenWallStreetZen

NASDAQ: MRSN
Mersana Therapeutics Inc Stock Ownership - Who owns Mersana Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Mersana Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Anna ProtopapasDirector2024-01-1629,399$2.71
$79.67kSell
Mohan BalaSVP Chief Development Officer2024-01-163,431$2.71
$9.30kSell
Alejandra CarvajalSVP Chief Legal Officer2024-01-164,381$2.71
$11.87kSell
Brian DeschuytnerSVP COO CFO2024-01-169,327$2.71
$25.28kSell
Timothy B. LowingerSVP Chief Sci.Tech. Officer2024-01-1610,409$2.71
$28.21kSell
Ashish MandeliaVP Chief Accounting Officer2024-01-165,025$2.71
$13.62kSell
Tushar MisraSVP Chief Manuf. Officer2024-01-163,357$2.71
$9.10kSell
Mohan BalaSVP Chief Development Officer2023-10-261,912$1.13
$2.16kSell
Tushar MisraSVP Chief Manuf. Officer2023-08-171,908$1.18
$2.25kSell

1 of 1

MRSN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MRSN insiders and whales buy or sell their stock.

MRSN Shareholders

What type of owners hold Mersana Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital LLC15.96%19,364,688$61.19MInsider
Ecor1 Capital LLC15.96%19,364,688$61.19MInstitution
Anthony A. Florence Jr.11.63%14,113,128$44.60MInsider
Patrick J. Kerins11.63%14,103,252$44.57MInsider
Forest Baskett11.49%13,934,092$44.03MInsider
Scott D. Sandell11.49%13,932,603$44.03MInsider
Peter W. Sonsini11.48%13,921,527$43.99MInsider
David M. Mott10.30%12,498,022$39.49MInsider
Vr Adviser LLC9.34%11,328,000$35.80MInstitution
Balyasny Asset Management LP7.99%9,698,147$30.65MInstitution

1 of 3

MRSN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MRSN42.94%57.06%Net Selling
ITOS62.37%37.63%Net Selling
BMEA61.83%38.17%Net Selling
CRBP5.76%94.24%Net BuyingNet Buying
ADPT62.07%37.93%Net SellingNet Selling
View Top Biotech Stocks

Mersana Therapeutics Stock Ownership FAQ

Who owns Mersana Therapeutics?

Mersana Therapeutics (NASDAQ: MRSN) is owned by 93.40% institutional shareholders, 124.11% Mersana Therapeutics insiders, and 0.00% retail investors. Ecor1 Capital LLC is the largest individual Mersana Therapeutics shareholder, owning 19.36M shares representing 15.96% of the company. Ecor1 Capital LLC's Mersana Therapeutics shares are currently valued at $61.39M.

If you're new to stock investing, here's how to buy Mersana Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.